Cambridge Healthtech Institute’s 2nd Annual

Oligonucleotide CMC and Regulatory Strategies

Accelerating Product Development and Commercial Success

March 17-18, 2020


CHI is delighted to build on the success of last years inaugural Oligonucleotide CMC and Regulatory Strategies to complement our Discovery and Delivery conference. We bring together top scientists and executives from leading biotech and large pharma to share exclusive insights on CMC, manufacturing, analytical and regulatory advancements. Learn how to optimise your product development processes and speed up time to market.


Coverage will include, but is not limited to:


  • Adoption and implementation of innovative technologies used in CMC and manufacturing 
  • Reducing costs and improving the efficiency of manufacturing processes   
  • When to outsource manufacturing and what to assess when doing so
  • Identifying the best analytical methods for characterizing impurities
  • How to prepare for a regulatory submission
  • Critical feedback on successful IND and NDA submissions
  • Overcoming common regulatory hurdles
  • Examining the safety and toxicity of nucleic acid therapeutics


If you would like to submit a proposal to give a presentation at this meeting, please click here.


The deadline for priority consideration is September 9th 2020.


All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.


For more details on the conference, please contact:
Gemma Smith

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+44) 7754-518-131


For partnering and sponsorship information, please contact:

Carolyn Cooke

Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5412



Oligonucleotide Discovery and Delivery